Tower Research Capital LLC (Trc) Grifols Sa Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Grifols Sa stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,790 shares of GRFS stock, worth $41,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,790
Previous 3,700
29.46%
Holding current value
$41,720
Previous $33,000
42.42%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...